Concepedia
Statistics
Publications
9
Citations
336
H-Index
Active since
1970
Affiliations
Pfizer (United States)(Current)
Merck & Co., Inc., Rahway, NJ, USA (United States)
Ken Kowalski is an author at Pfizer (United States) specializing in pharmacology, medicine, and pharmacotherapy.
Top concepts
MedicinePharmacologyPharmacotherapyHealthSurgeryDiabetesGlaucomaAnalgesicsAnesthesiaNephrology
Publications per year
1970–2022
Analgesic efficacy of celecoxib in postoperative oral surgery pain: A single-dose, two-center, randomized, double-blind, active- and placebo-controlled study
Raymond Cheung, Sriram Krishnaswami, Ken Kowalski · Clinical Therapeutics · 2007 · 63 citations
Pain Therapy, Health Sciences, Pain Medicine +11
A Quantitative Approach for Making Go/No-Go Decisions in Drug Development
Christy Chuang‐Stein, Simon Kirby, Jonathan French et al. · Drug Information Journal · 2011 · 57 citations
Drug Repositioning, Go/no-go Decisions, Drug Design +8
Changes in serum creatinine in patients with active rheumatoid arthritis treated with tofacitinib: results from clinical trials
John D. Isaacs, Andrea Zuckerman, Sriram Krishnaswami et al. · Arthritis Research & Therapy · 2014 · 50 citations · Full text
Population PK Analyses of Ubrogepant (MK‐1602), a CGRP Receptor Antagonist: Enriching In‐Clinic Plasma PK Sampling With Outpatient Dried Blood Spot Sampling
Chi‐Chung Li, Marissa F. Dockendorf, Ken Kowalski et al. · The Journal of Clinical Pharmacology · 2017 · 41 citations
Population Pharmacokinetics and Exposure–Response Analyses of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease
Omoniyi J. Adedokun, Zhenhua Xu, Christopher Gasink et al. · Clinical Therapeutics · 2022 · 37 citations
1–5 of 9